1 – 10 of 1245
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Levels of DNA damage (Micronuclei) in patients suffering from chronic kidney disease. Role of GST polymorphisms
- Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer
- GFR-gränsen har sänkts för metformin vid typ 2-diabetes : Nya rekommendationer vid nedsatt njurfunktion och undersökning med jodkontrastmedel
- Maximally effective dosing regimens of meropenem in patients with septic shock
- High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate
- Prophylactic 3-hour graduated infusion schedule minimizes risk of carboplatin hypersensitivity reactions - A prospective study
- Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients
- A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer
- Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort
- Updated European Association of Urology Guidelines : Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer